These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Improved tolerability and quality of life with the new lopinavir/ritonavir tablet formulation. Olmo M; Ferrer E; Curto J; Barragán P; Saumoy M; Perulero N; Podzamczer D J Infect; 2008 Dec; 57(6):503-5. PubMed ID: 18952298 [No Abstract] [Full Text] [Related]
5. Anti-HIV agents. Using only lopinavir/ritonavir (Kaletra). TreatmentUpdate; 2008 Jan; 20(1):1-2. PubMed ID: 18320690 [No Abstract] [Full Text] [Related]
6. CASTLE data show no gender differences. AIDS Patient Care STDS; 2008 Sep; 22(9):762. PubMed ID: 18802980 [No Abstract] [Full Text] [Related]
7. Women and non-whites new to HAART respond similarly to men and whites. AIDS Patient Care STDS; 2008 Sep; 22(9):762. PubMed ID: 18802978 [No Abstract] [Full Text] [Related]
9. Pharmacokinetic interactions between rifabutin and lopinavir/ritonavir in HIV-infected patients with mycobacterial co-infection. Khachi H; O'Connell R; Ladenheim D; Orkin C J Antimicrob Chemother; 2009 Oct; 64(4):871-3. PubMed ID: 19628472 [No Abstract] [Full Text] [Related]
10. Kaletra single agent HAART after intolerance of NRTI- and NNRTI-containing regimens following kidney transplantation. Schürmann D; Wesselmann H; Kurowski M; Suttorp N; Reinke P Infection; 2007 Jun; 35(3):194-6. PubMed ID: 17565464 [TBL] [Abstract][Full Text] [Related]
11. HIV postexposure prophylaxis after sexual assault: why is it so hard to accomplish? Cohen MS Sex Transm Dis; 2008 Dec; 35(12):979-80. PubMed ID: 18955917 [No Abstract] [Full Text] [Related]
12. Response to "Nifedipine-lopinavir/ritonavir severe interaction: a case report". Back DJ; Gibbons SE AIDS; 2007 May; 21(9):1226-7. PubMed ID: 17502742 [No Abstract] [Full Text] [Related]
13. Two studies show Kaletra and Isentress similarly suppress HIV, yet have different side effects. Proj Inf Perspect; 2009 Mar; (48):6. PubMed ID: 19492458 [No Abstract] [Full Text] [Related]
15. Aluvia tablet approved in 19 African countries. AIDS Patient Care STDS; 2007 Aug; 21(8):604-5. PubMed ID: 17902244 [No Abstract] [Full Text] [Related]
16. The state of access to Kaletra. Huff B GMHC Treat Issues; 2006; 20(4-7):4-5. PubMed ID: 17228448 [No Abstract] [Full Text] [Related]
17. FDA notifications. FDA approves half-strength Kaletra. AIDS Alert; 2008 Jan; 23(1):10. PubMed ID: 18572474 [No Abstract] [Full Text] [Related]
18. FDA notifications. Abbott sends out provider letter about Kaletra for kids. AIDS Alert; 2007 Oct; 22(10):118. PubMed ID: 18416010 [No Abstract] [Full Text] [Related]
19. Kaletra lower-strength pediatric tablet approved in Europe. AIDS Patient Care STDS; 2008 May; 22(5):437-8. PubMed ID: 18521973 [No Abstract] [Full Text] [Related]
20. Uveitis associated with concurrent administration of rifabutin and lopinavir/ritonavir (Kaletra). Lin HC; Lu PL; Chang CH Eye (Lond); 2007 Dec; 21(12):1540-1. PubMed ID: 17962822 [No Abstract] [Full Text] [Related] [Next] [New Search]